C. Crimi (Catania (CT), Italy), S. Kaul (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Persisting immune response to SARS-CoV-2 in a local Austrian population
D. Ladage (Moenchengladbach, Germany), O. Harzer (Ingelheim, Germany), H. Winkler (Krems, Austria), A. Knies (Krems, Austria), M. Schneider (Krems, Austria), R. Wagner (Krems, Austria), P. Engel (Krems, Austria), W. Frank (Krems, Austria), R. Braun (Krems, Austria)
|  |
Bacterial respiratory co-infections of patients hospitalized with COVID-19: a prospective microbiologic study in single tertiary hospital in Kazakhstan
N. Bissenova (Nur-Sultan, Kazakhstan), A. Yergaliyeva (Nur-Sultan, Kazakhstan)
| |
Clinical and biologic risk factors for mortality in the first 6 months of SARS-Cov2 in a Romanian hospital
D. Zaharia (Bucuresti, Romania), A. Muntean (Bucuresti, Romania), A. Cristea (Bucuresti, Romania), A. Dragomir (Bucuresti, Romania), E. Ibraim (Bucuresti, Romania), G. Ciolan (Bucuresti, Romania), E. Athir (Bucuresti, Romania), I. Bulacu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), O. Parliteanu (Bucuresti, Romania), S. Leu (Bucuresti, Romania), S. Dumitru (Bucuresti, Romania), A. Andru (Bucuresti, Romania), N. Chelaru (Bucuresti, Romania), O. Grigore (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), C. Toma (Bucuresti, Romania), I. Strambu (Bucuresti, Romania)
|  |
Predictors of severe COVID-19 disease in the inpatient cohort, Russian Federation.
G. Kaminskiy (Moscow, Russian Federation), E. Veselova (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), T. Tyulkova (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation)
| |
Prevalence and impact of comorbidities in Tunisian moderate to severe COVID-19 patients
L. Kaabi (tunis, Tunisia), S. Louhaichi (tunis, Tunisia), I. Khalfallah (tunis, Tunisia), R. Jebali (tunis, Tunisia), S. Marzouki (tunis, Tunisia), M. Kharrat (tunis, Tunisia), J. Ammar (tunis, Tunisia), A. Hamzaoui (tunis, Tunisia)
| |
COVID-19 pneumonia in Galicia (Spain): impact of prognostic factors and therapies on mortality and need for mechanical ventilation
I. Guzman Peralta (Lugo, Spain), L. Perez De Llano (Lugo, Spain), E. Romay-Lema (Lugo, Spain), A. Baloira Villar (Pontevedra, Spain), C. Anchorena Diaz (Pontevedra, Spain), M. Torres Durán (Vigo, Spain), A. Sousa (Vigo, Spain), D. Corbacho-Abelaira (Vigo, Spain), C. Diego-Roza (Ferrol, Spain), L. Vilariño-Maneiro (Ferrol, Spain), P. Marcos (Coruña, Spain), C. Montero Martínez (Coruña, Spain), F. De La Iglesia Martínez (Coruña, Spain), V. Riveiro-Blanco (Santiago, Spain), N. Rodríguez Nuñez (Santiago, Spain), J. Abal-Arca (Ourense, Spain), M. Bustillo Casado (Ourense, Spain), R. Golpe (Lugo, Spain)
| |
Factors predicting the onset of Covid-19 among healthcare workers at Hassan II hospital in Agadir
A. Khannous (Agadir, Morocco), F. Bounoua (Agadir, Morocco), L. Manssouri (Agadir, Morocco), H. Moubachir (Agadir, Morocco), H. Serhane (Agadir, Morocco)
| |
Severe prognosis factors linked to Covid-19 patients hospitalized at Hassan II hospital in Agadir
A. Khannous (Agadir, Morocco), F. Bounoua (Agadir, Morocco), H. Jamil (Agadir, Morocco), I. Esserfati (Agadir, Morocco), H. Moubachir (Agadir, Morocco), H. Serhane (Agadir, Morocco)
| |
Telemedicine solutions for patients in intensive care unit with Covid-19 in Russia
M. Brovko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), N. Trushenko (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), A. Moiseev (Moscow, Russian Federation), A. Kitbalyan (Moscow, Russian Federation), P. Potapov (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), V. Fomin (Moscow, Russian Federation)
| |
Thromboembolic events in COVID-19 patients : A Tunisian case series study.
S. Louhaichi (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), N. Boubaker (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
| |
SARS-CoV-2 infection in transplant recipients: experience of a COVID-19 unit in Portugal
M. Oliveira Pinto (Lisboa, Portugal), S. Fernandes (Lisboa, Portugal), J. Rodrigues (Lisboa, Portugal), A. Pinto (Lisboa, Portugal), E. Leal (Lisboa, Portugal), M. Torres (Lisboa, Portugal), S. Betkova (Lisboa, Portugal), R. Gonçalves (Lisboa, Portugal), A. Santos (Lisboa, Portugal), S. Lino (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), F. Maltez (Lisboa, Portugal)
| |
Hyperglycemia and diabetes mellitus as mortality risk factors in 600 COVID-19 Romanian patients
D. Zaharia (Bucuresti, Romania), A. Cristea (Bucuresti, Romania), A. Dragomir (Bucuresti, Romania), E. Ibraim (Bucuresti, Romania), G. Ciolan (Bucuresti, Romania), E. Athir (Bucuresti, Romania), I. Bulacu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), O. Parliteanu (Bucuresti, Romania), S. Leu (Bucuresti, Romania), S. Dumitru (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), C. Toma (Bucuresti, Romania), I. Strambu (Bucuresti, Romania)
| |
Mortality risk in a Romanian cohort of patients hospitalised for COVID-19
S. Frent (Timisoara, Romania), A. Bikov (Manchester, United Kingdom), E. Bobu (Timisoara, Romania), R. Pleava (Kungälv, Sweden), C. Serban (Timisoara, Romania), I. Marincu (Timisoara, Romania), M. Marc (Timisoara, Romania), S. Mihaicuta (Timisoara, Romania), C. Oancea (Timisoara, Romania)
| |
First and second wave of COVID-19 in Tunisia:A comparative study among patients hospitalized in a medicine department
r. Jbeli (ariana, Tunisia), S. Louhaichi (ariana, Tunisia), I. Khlfallah (ariana, Tunisia), S. Marzouki (ariana, Tunisia), L. Kaabi (ariana, Tunisia), S. Elfidha (ariana, Tunisia), J. Ammar (ariana, Tunisia), B. Hamdi (ariana, Tunisia), A. Hamzaoui (ariana, Tunisia)
| |
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
N. Kokturk (Ankara, Turkey), C. Babayigit (Antakya, Turkey), S. Kul (Gaziantep, Turkey), P. Cetinkaya (Adana, Turkey), S. Nayci (Mersin, Turkey), S. Baris (Kocaeli, Turkey), O. Karcioglu (Ankara, Turkey), P. Aysert (Ankara, Turkey), I. Irmak (Ankara, Turkey), A. Yuksel (Ankara, Turkey), Y. Sekibag (Istanbul, Turkey), O. Toprak (Adana, Turkey), E. Azak (Kocaeli, Turkey), S. Mulamahmutoglu (Istanbul, Turkey), C. Cuhadaroglu (Istanbul, Turkey), A. Demirel (Istanbul, Turkey), B. Kerget (Erzurum, Turkey), B. Ketencioglu (Kayseri, Turkey), H. Ozger (Ankara, Turkey), G. Ozkan (Istanbul, Turkey), Z. Yüce (Kayseri, Turkey), B. Ergan (Izmir, Turkey), V. Avkan Oguz (Izmir, Turkey), O. Kilinc (Izmir, Turkey), M. Ercelik (Düzce, Turkey), T. Ciftci (Ankara, Turkey), O. Alici (Istanbul, Turkey), E. Temel (Isparta, Turkey), O. Ataoglu (Düzce, Turkey), A. Aydin (Bursa, Turkey), D. Bahcetepe (Bursa, Turkey), Y. Gullu (Samsun, Turkey), F. Fakili (Gaziantep, Turkey), F. Deveci (Elazig, Turkey), N. Kose (Bilecik, Turkey), M. Tor (Zonguldak, Turkey), G. Gunluoglu (Istanbul, Turkey), S. Altin (Istanbul, Turkey), T. Turgut (Elazig, Turkey), T. Tuna (Samsun, Turkey), O. Ozturk (Isparta, Turkey), O. Dikensoy (Istanbul, Turkey), P. Gulhan (Duzce, Turkey), I. Basyigit (Kocaeli, Turkey), H. Boyaci (Kocaeli, Turkey), I. Oguzulgen (Ankara, Turkey), S. Borekci (Istanbul, Turkey), B. Gemicioglu (Istanbul, Turkey), F. Bayraktar (Izmir, Turkey), O. Elbek (Istanbul, Turkey), I. Hanta (Adana, Turkey), H. Okur (Istanbul, Turkey), G. Sagcan (Istanbul, Turkey), O. Uzun (Samsun, Turkey), M. Akgun (Erzurum, Turkey), G. Altinisik (Denizli, Turkey), B. Dursun (Ankara, Turkey), E. Edis (Edirne, Turkey), E. Gulhan (Ankara, Turkey), F. Eyuboglu (Ankara, Turkey), O. Gultekin (Manisa, Turkey), Y. Havlucu (Manisa, Turkey), M. Ozkan (Ankara, Turkey), A. Sakar (Manisa, Turkey), A. Sayiner (Izmir, Turkey), A. Kalyoncu (Ankara, Turkey), O. Itil (Izmir, Turkey), H. Bayram (Izmir, Turkey)
| |
Risk Factors for Mortality of COVID-19 Confirmed Cases Admitted at Lung Center of the Philippines
M. DE VERA (QUEZON CITY, Philippines), G. Ombao (QUEZON CITY, Philippines), V. De Los Reyes (QUEZON CITY, Philippines)
| |
Clinical and epidemiological features of SARS-CoV-2 infection among hospitalized children in Ukraine
Y. Antipkin (Kyiv, Ukraine), V. Podolskiy (Kyiv, Ukraine), V. Podolskiy (Kyiv, Ukraine), V. Lapshyn (Kyiv, Ukraine), T. Umanets (Kyiv, Ukraine), T. Kaminska (Kyiv, Ukraine), . Livshits (Kyiv, Ukraine), T. Harashchenko (Kyiv, Ukraine)
| |
SARS-CoV-2 seropositivity in asymptomatic frontline health workers in Ibadan, Nigeria
O. Olayanju (Cape Town, South Africa), O. Bamidele (Ibadan, Nigeria), F. Edem (Ibadan, Nigeria), B. Eseile (Ibadan, Nigeria), J. Nwaokenye (Ibadan, Nigeria), C. Udeh (Ibadan, Nigeria), G. Odok (Ibadan, Nigeria), N. Awah (Ibadan, Nigeria)
| |
Predictors of COVID-19-related mortality: experience of the isolation unit at the Gabes regional hospital
W. Ghribi (Gabes, Tunisia), S. Majdoub Fehri (Gabes, Tunisia), D. El Euch (Gabes, Tunisia), K. Abdelmouleh (Gabes, Tunisia), A. Gnounou (Gabes, Tunisia), H. Ghorbel (Gabes, Tunisia), H. Kwass (Gabes, Tunisia)
| |
Correlates of the SARS-CoV-2 Ag or Total Ig antibody levels with hematological parameters in Greek hospitalized COVID-19 patients.
E. Rouka (Larissa, Greece), O. Kotsiou (Larissa, Greece), G. Perlepe (Larissa, Greece), A. Pagonis (Larissa, Greece), I. Pantazopoulos (Larissa, Greece), K. Gourgoulianis (Larissa, Greece)
| |